Erika Huijser
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Cross reactivity of endogenous and exogenous 25-hydroxyvitamin D2 in commercial vitamin D assays; an evaluation using the Dutch external quality assessment scheme.
Journal: Clinical chemistry and laboratory medicine
Published: June 19, 2025
Two new cases of KYNU deficiency: Further delineation of the phenotypic and biochemical spectrum and exploration of treatment options.
Journal: Molecular genetics and metabolism
Published: May 28, 2025
Extranodal marginal zone lymphoma clonotypes are detectable prior to eMZL diagnosis in tissue biopsies and peripheral blood of Sjögren's syndrome patients through immunogenetics.
Journal: Frontiers in oncology
Published: December 23, 2022
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort.
Journal: Rheumatology (Oxford, England)
Published: September 06, 2022
Trained Immunity in Primary Sjögren's Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype.
Journal: Frontiers in immunology
Published: December 21, 2021
Genetic Variants of the BAFF Gene and Risk of Fatigue Among Patients With Primary Sjögren's Syndrome.
Journal: Frontiers in immunology
Published: December 15, 2021
Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
Journal: Rheumatology (Oxford, England)
Published: October 13, 2021
Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome.
Journal: Rheumatology (Oxford, England)
Published: April 02, 2021
Making Sense of Intracellular Nucleic Acid Sensing in Type I Interferon Activation in Sjögren's Syndrome.
Journal: Journal of clinical medicine
Published: December 23, 2020
Inverse correlation between serum complement component C1q levels and whole blood type-1 interferon signature in active tuberculosis and QuantiFERON-positive uveitis: implications for diagnosis.
Journal: Clinical & translational immunology
Published: April 24, 2020
MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis.
Journal: Rheumatology (Oxford, England)
Published: February 11, 2019
Last Updated: 09/26/2026